Skip to main content

Sanofi news in 2026: 33 dated events

The latest Sanofi event on this page is dated Oct 30, 2026. globenewswire.com reported: Press Release: Q3 2026: double-digit growth in sales and business EPS FY 2026: guidance upgraded.

PublicPharmaceutical Manufacturing10,000+ employeessanofi.comLinkedIn

Get Sanofi's live signals in Claude or ChatGPT, or by API

AskWhat changed at Sanofi this week? Use Autobound signals for sanofi.com.
Dated events
33
Last 90 days
24
Latest
Oct 30, 2026

Source: Autobound Signal API · 81 signals tracked for Sanofi · updated

News · latest 10

Latest Sanofi news

  1. Partnership
  2. In development
    Novavax Earns $125 Million Milestone as Sanofi Launches Phase 3 Influenza-COVID-19 Combination Vaccine Trial in EuropeSanofi initiated a Phase 3 clinical trial in Europe evaluating an influenza-COVID-19 combination vaccine utilizing Novavax's Nuvaxovid and Sanofi's Efluelda/Fluzone High-Dose.
  3. Partnership
  4. Partnership
    Sanofi Stock: ScionxBio optimizes mRNA candidatesSanofi entered into a global collaboration and licensing agreement with ScionxBio to develop extended-exposure variants of selected mRNA candidates.
  5. Award
    ISPE Names Sanofi S.A. the 2026 ISPE Facility of the Year Awards (FOYA) Overall Winner for its Modulus ProjectSanofi S.A. was recognized as the FOYA Overall Winner of the 2026 ISPE Facility of the Year Awards for its Modulus project.
  6. In development
    Sanofi Exercises Option on Recursion's First Development Candidate, Triggering a $10 Million Milestone PaymentSanofi exercised its option on Recursion's first development candidate, advancing an oral small molecule for inflammatory diseases into its pipeline with Phase 1 trials expected in 2027.
  7. In development
    Recursion Announces Sanofi Options Potential First-in-Class Immunology Development Candidate from Their CollaborationSanofi has optioned and added a potential first-in-class oral small molecule immunology development candidate to its development pipeline from its research collaboration with Recursion.
  8. Earnings
    Sanofi Stock: 8 Billion Partnership with Regeneron Weighs DownSanofi announced it will publish its financial results for the third quarter of 2026 on October 30, 2026.
  9. Partnership
    Sanofi Sinks Toward 52-Week Low as Regeneron Deal Raises Cost Questions$1B · With Regeneron Pharmaceuticals · 2 stories
  10. Revenue

Showing 10 of 33 dated events. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Sanofi with the Signal API

One POST /v1/companies/enrich call with sanofi.com returns Sanofi news signals (news), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"sanofi.com","signal_types":["news"],"limit":20}'

Bulk data

Need this signal for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real News records, as a CSV.

Talk to sales

Same industry

Questions about Sanofi news

What is the latest news on Sanofi?
The newest event on this page is dated Oct 30, 2026. globenewswire.com reported: Press Release: Q3 2026: double-digit growth in sales and business EPS FY 2026: guidance upgraded. This page lists 33 dated events for Sanofi, each with a source link.
What is going on with Sanofi?
The 10 latest events on this page cover partnership (4), in development (3), award (1), earnings (1) and revenue (1). The newest: Oct 30, 2026: Press Release: Q3 2026: double-digit growth in sales and business EPS FY 2026: guidance upgraded (globenewswire.com).

Page updated , the date of the newest row on this page.

Source. News articles about the company, one source link per event.

Method. Stories about the same event within 14 days merge into one row. Noise (lists, stock tips, recaps) is removed.

Data as of .

How this data is built →Get it from the Signal API →